Atlas Trials

Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer

Clinical trial NCT00603863 · COMPLETED

Trial details

NCT number
NCT00603863
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2008-01-01
Primary completion
2013-07-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.